
Episode #104
Redefining Cancer Treatment: Interview with Dr. Charles Link on Sync-T and the Future of Immunotherapy
<p>Join host Bree Clare as she speaks with Dr. Charles Link, a pioneering oncologist and immunotherapy researcher who's spent decades reshaping the landscape of cancer medicine. </p> <p>In this episode, Dr. Link breaks down SYNC-T, a revolutionary in-situ immunotherapy platform that's redefining treatment possibilities for hard-to-treat cancers. We'll explore how this multi-target immunotherapy works to educate the immune system to recognize and attack cancer and learn about an exciting Phase 2 clinical trial now enrolling patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).</p> <p>Whether you're a patient, caregiver, researcher, or simply seeking hope and inspiration at the frontiers o...

